- Uniper warns that gas prices are unlikely to drop; if the Strait of Hormuz does not reopen, prices of 50 to 60 euros will become the norm
- SEA's Q2 revenue was $7.788 billion, up 48.1% year-on-year; diluted earnings per share were $0.70, an increase of 7.7% year-on-year.
- Brent crude and US crude oil gave back some of their gains as a spokesperson for the Qatari government stated that negotiations between Oman and Iran have entered an advanced stage.
- Commerzbank: Raises European natural gas price forecast, now expects €50/MWh by end of 2026, previously projected at €45/MWh
- Foreign media: Software stocks and bitcoin show rare divergence in performance
- NATIONAL ENERGY SERVICES REUNITED CORP. <NESR.O>: BARCLAYS RAISES TARGET PRICE TO $45 FROM $35
- Cardinal Health signs $4 billion revolving credit facility, replacing existing lines
- Bitcoin traders assess macroeconomic factors for future outlook
- Goodland to use completed 1377 Serangoon Road commercial building as new HQ, investment property
- RH <RH.N>: WELLS FARGO RAISES TARGET PRICE TO $225 FROM $175
- HIMS & HERS HEALTH, INC. <HIMS.N>: CITIGROUP CUTS TARGET PRICE TO $33 FROM $35
- Singapore Land dissolves Peak Venture joint venture after voluntary liquidation
- IHS Towers Q2 FY26 turns to IFRS net loss of USD 7.5 million; revenue from continuing operations rises 10.4% to USD 428.6 million
- Lithium Argentina 2Q EPS C$0.01 >LAR.T
- The main Brent crude oil futures contract just reached the $89.00/barrel mark, now quoted at $89.00/barrel, up 1.33% on the day.
- Finnish government bond auction sees moderate demand as long-term yields surpass 3.9%, with a pronounced curve steepening trend
- Spot gold has just broken through the $4,380.00/oz mark, and is now quoted at $4,380.07/oz, down 0.23% on the day; the main COMEX gold futures contract is quoted at $4,439.00/oz, up 0.44% on the day.
- SYNOPSYS, INC. <SNPS.O>: WELLS FARGO CUTS TARGET PRICE TO $450 FROM $535
- THE E.W. SCRIPPS CO. <SSP.O>: WELLS FARGO CUTS TARGET PRICE TO $3.8 FROM $4.7
- OPTIMUM COMMUNICATIONS, INC. <OPTU.N>: WELLS FARGO CUTS TARGET PRICE TO $0.75 FROM $1
- METAGENOMI THERAPEUTICS, INC. <MGX.O>: WELLS FARGO CUTS TARGET PRICE TO $7 FROM $9
- NIQ GLOBAL INTELLIGENCE PLC <NIQ.N>: WELLS FARGO RAISES TARGET PRICE TO $16.5 FROM $13
- AXSOME THERAPEUTICS, INC. : WELLS FARGO RAISES TARGET PRICE TO $256 FROM $255
- AGILON HEALTH, INC. : WELLS FARGO RAISES TARGET PRICE TO $146 FROM $141
- THE PENNANT GROUP, INC. : WELLS FARGO RAISES TARGET PRICE TO $46 FROM $45
- CONCENTRA GROUP HOLDINGS PARENT, INC. <CON.N>: WELLS FARGO RAISES TARGET PRICE TO $40 FROM $28
- MEDLINE, INC. <MDLN.O>: WELLS FARGO CUTS TARGET PRICE TO $34 FROM $45
- MCKESSON CORPORATION <MCK.N>: WELLS FARGO RAISES TARGET PRICE TO $933 FROM $812
- THE HOME DEPOT, INC. <HD.N>: WELLS FARGO RAISES TARGET PRICE TO $400 FROM $360
- CENCORA INC. <COR.N>: WELLS FARGO RAISES TARGET PRICE TO $395 FROM $331
- BRIDGEBIO PHARMA, INC. <BBIO.O>: WELLS FARGO RAISES TARGET PRICE TO $102 FROM $98
- BEST BUY COMPANY, INC. <BBY.N>: WELLS FARGO RAISES TARGET PRICE TO $85 FROM $65
- LOWE'S COMPANIES, INC. <LOW.N>: WELLS FARGO CUTS TARGET PRICE TO $245 FROM $255
- WILLIAMS-SONOMA, INC. <WSM.N>: WELLS FARGO RAISES TARGET PRICE TO $240 FROM $190
- Singapore Land FY26 H1 PATMI rises 90% to S$ 211.75 million; revenue increases 2% to S$ 376.77 million
- PAR PACIFIC HOLDINGS INC : MIZUHO RAISES TARGET PRICE TO $85 FROM $80
- Lithium Argentina swings to Q2 FY26 net income of $1.3 million; income rises to $2.3 million
- MARATHON PETROLEUM CORPORATION <MPC.N>: MIZUHO RAISES TARGET PRICE TO $304 FROM $284
- DELEK US HOLDINGS INC <DK.N>: MIZUHO RAISES TARGET PRICE TO $66 FROM $60
- Hyperscale Data Has Begun Discussions With Major Investment Banking Firm >GPUS
- Hyperscale Data: Range of Alternatives Include Potential Sale or Lease of Portion or All of Data Center for Cash, Strategic Investment or Joint Venture or Continued Ownership and Development of the Assets >GPUS
- FIVE BELOW, INC. <FIVE.O>: MIZUHO RAISES TARGET PRICE TO $260 FROM $220
- Hyperscale Data: Strategic Alternatives Include Sale for Cash and Strategic Partnerships, Among Other Options >GPUS
- Easterly Government Properties posts investor deck on government-leased, mission-critical real estate portfolio and growth pipeline
- BlackRock reports 5.19% stake in Heidelberg Materials
- Duke Energy seeks NYSE listing for $1.75 billion equity units
- Orezone Gold reports high-grade drill intercepts at Bomboré mine ahead of Q1 2027 resource update
- Twenty One Capital Q2 FY26 net loss widens to $413.54 million; operating loss widens to $10.73 million
- Sea Q2 FY26 net income rises 10.6% to US$458.1 million; revenue jumps 48.1% to US$7.8 billion
- BioHarvest Q2 FY26 net loss narrows to USD 3.7 million; revenue rises 3.8% to USD 8.8 million
- Carolina Rush signs nine mineral leases covering 2,524 acres near Brewer project in South Carolina
- Japan Gold completes 21.3-km CSAMT/AMT geophysical survey at Mizobe project in Japan
- Immunic 2Q Research and Development Expenses $25.9M >IMUX
- Hyperscale Data signs 20-MW AI compute services deal valued at $1.2 billion
- Silverco Mining names Jesus Velador vice president of exploration
- Americas Gold and Silver to host Q2 2026 results conference call and webcast
- SPROUT SOCIAL, INC. <SPT.O>: BARCLAYS RAISES TARGET PRICE TO $12 FROM $9
- RAPID7 <RPD.O>: BARCLAYS RAISES TARGET PRICE TO $12 FROM $6.5
- POST HOLDINGS, INC. : BARCLAYS CUTS TARGET PRICE TO $95 FROM $106
- Aramark FY26 Q3 net income rises 36% to $97.83 million; revenue increases 9% to $5.1 billion
- WW GRAINGER INC. <GWW.N>: BARCLAYS RAISES TARGET PRICE TO $1185 FROM $1166
- FERGUSON ENTERPRISES INC. <FERG.N>: BARCLAYS RAISES TARGET PRICE TO $313 FROM $297
- IDEXX LABORATORIES, INC. <IDXX.O>: BARCLAYS CUTS TARGET PRICE TO $710 FROM $800
- INNOVEX INTERNATIONAL INC. <INVX.N>: BARCLAYS RAISES TARGET PRICE TO $27 FROM $26
- FAIR ISAAC CORP. <FICO.N>: BARCLAYS CUTS TARGET PRICE TO $1700 FROM $1950
- EXCELERATE ENERGY INC <EE.N>: BARCLAYS RAISES TARGET PRICE TO $43 FROM $41
- ASPEN AEROGELS INC. : BARCLAYS RAISES TARGET PRICE TO $5 FROM $4
- BROOKDALE SENIOR LIVING INC. <BKD.N>: BARCLAYS CUTS TARGET PRICE TO $17 FROM $18
- BKV CORPORATION <BKV.N>: BARCLAYS RAISES TARGET PRICE TO $36 FROM $35
- ABERCROMBIE & FITCH CO. : BARCLAYS RAISES TARGET PRICE TO $114 FROM $78
- ABERCROMBIE & FITCH CO. : BARCLAYS RAISES TARGET PRICE TO $114 FROM $78
- STANDARD NUCLEAR, INC. <STDN.N>: BARCLAYS INITIATES COVERAGE WITH OVERWEIGHT RATING AND TARGET PRICE $17
- THE GAP, INC. <GAP.N>: BARCLAYS CUTS TARGET PRICE TO $20 FROM $26
- THE GAP, INC. <GAP.N>: BARCLAYS CUTS TARGET PRICE TO $20 FROM $26
- UNDER ARMOUR, INC. <UAA.N>: BARCLAYS CUTS TO UNDERWEIGHT FROM EQUAL-WEIGHT
- ALTRIA GROUP INC. <MO.N>: BARCLAYS CUTS TARGET PRICE TO $58 FROM $64
- ResMed CEO Michael J. Farrell reports disposal of 4,991 common shares worth $1,026,594.05
- BRIEF-Pet Valu Q2 Net Income CAD 24.933 Million
- BRIEF-Cineplex Q2 EPS CAD 0.12
- BRIEF-Aramark Q3 EPS USD 0.36
- Immunic Q2 net loss widens to $34.1 million; operating expenses rise to $35.3 million
- Westwater Resources schedules webcast on second-quarter 2026 results
- Cineplex Q2 FY26 net income turns to profit at CAD 7.8 million; revenue rises 9.8% to CAD 383.7 million
- XCF Global sells renewable diesel from Reno refinery to Tartan Oil
- Parsons wins $40 million US Army electronic warfare contract
- Babcock & Wilcox signs Siemens Energy deal to start work on 20 steam turbines for data centers
- Pet Valu Holdings 2Q EPS 37c >PET.T
- Cineplex 2Q Rev C$383.7M >CGX.T
- Cineplex 2Q EPS C$0.12 >CGX.T
- Immunic 2Q Loss/Shr 80c >IMUX
- Venture Global 2Q Net $1.42B >VG
- Venture Global 2Q EPS 51c >VG
- Venture Global 2Q Consolidated Adj Ebitda $2.5B >VG
- Venture Global: Exported 127 Cargos and Sold 466.4 TBtu of Liquefied Natural Gas in 2Q >VG
- Venture Global Now Sees 2026 Consolidated Adj Ebitda $8.7B-$9.1B, Up From Prior View $8.2B-$8.5B >VG
- Venture Global: Xpect to Export 149-154 Cargos From Calcasieu Pass and 351-364 Cargos From Plaquemines in 2026 >VG
- Aramark 3Q Rev $5.06B >ARMK
- U.S. Political, Economic Calendar - Week Ahead
- Immunic 2Q Loss $34.1M >IMUX
- Genesis Energy expects FY26 adjusted EBITDA at low end of $575 million-$612 million guidance range
